About
Science
Publications
Team
News
Careers
Contact us
inWhite
tw_white-black
MoreMenu
CloseWhite
About
Science
Publications
Team
News
Careers
Contact us
inWhite
tw_white-black
News
Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy
Asgard Therapeutics appoints immunology expert Shane Olwill as Chief Development Officer
Asgard Therapeutics’ study published in Science showing proof-of-concept and strong anti-tumor responses via in vivo cell reprogramming with lead program AT-108
Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
Asgard Therapeutic’s scientific founders join forces with Lund University to incorporate Asgard Therapeutics
Posted 26 December, 2018